Ling Xie

机构：University of North Carolina at Chapel Hill, Segeberger Kliniken, UNC Lineberger Comprehensive Cancer Center

发表论文 61 篇 · 总被引 5247 次 · h-index 27

代表论文

• Bridged Proteolysis Targeting Chimera (PROTAC) Enables Degradation of Undruggable Targets (2022 · Journal of the American Chemical Society · 被引 140)
• TF-DUBTACs Stabilize Tumor Suppressor Transcription Factors (2022 · Journal of the American Chemical Society · 被引 64)
• Targeting Triple-Negative Breast Cancer by a Novel Proteolysis Targeting Chimera Degrader of Enhancer of Zeste Homolog 2 (2022 · ACS Pharmacology & Translational Science · 被引 64)
• Histone H3 proline 16 hydroxylation regulates mammalian gene expression (2022 · Nature Genetics · 被引 52)
• The Cytidine N-Acetyltransferase NAT10 Participates in Peripheral Nerve Injury-Induced Neuropathic Pain by Stabilizing SYT9 Expression in Primary Sensory Neurons (2023 · Journal of Neuroscience · 被引 39)
• Structurally Specific Z-DNA Proteolysis Targeting Chimera Enables Targeted Degradation of Adenosine Deaminase Acting on RNA 1 (2024 · Journal of the American Chemical Society · 被引 33)